Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-11 · accession 0001209191-22-009337 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-14 | 2022-02-11 | IART | Coleman Glenn | EVP, COO | A - Grant | $0.00 | +29.3K | 57.5K | +104% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-11 | A | A | 5,892 | $0.00 | 34,046 | D | — | — | (F1) On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date. (F2) Includes 373 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4. |
| 2 | Common | Common Stock | 2022-02-11 | A | A | 10,837 | $0.00 | 44,883 | D | — | — | (F3) On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date. |
| 3 | Common | Common Stock | 2022-02-11 | A | A | 12,576 | $0.00 | 57,459 | D | — | — | (F4) On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date. |